市場調查報告書
商品編碼
1307988
動物抗生素和抗菌劑市場 - 按產品類型(四環素類、青黴素類、磺胺類、大環內酯類、氨基糖苷類、林可黴素類、氟喹諾酮類、頭孢菌素類)、給藥方式、動物類型和全球預測2023-2032年Animal Antibiotics and Antimicrobials Market - By Product Type (Tetracyclines, Penicillin, Sulfonamides, Macrolides, Aminoglycosides, Lincosamides, Fluoroquinolones, Cephalosporins), By mode of delivery, Animal Type & Global Forecast 2023-2032 |
全球動物抗生素和抗菌劑市場將在2023-2032年期間大幅成長,其驅動因素是動物源性蛋白質的消費量和攝入量不斷增加。
全球對動物源性蛋白產品的需求不斷增加,加上人口不斷成長,導致集約化動物養殖方式增多,從而增加了疾病爆發的風險。這就需要使用抗生素和抗菌劑來預防和治療家畜感染,從長遠來看,這將推動市場收入的成長。人畜共患病發病率的上升以及對疾病控制措施的需求進一步促進了市場成長。
根據美國疾病預防控制中心(CDC)的數據,科學家估計每10種已知的人類傳染病中就有6種以上可通過動物傳播,每4種新的或新出現的人類傳染病中就有3種通過動物傳播。此外,良好的政府法規促進了抗生素的合理使用,並實施了嚴格的動物健康管理準則,這對市場的形成起著至關重要的作用。
整個動物抗生素和抗菌劑市場根據產品、給藥方式、動物和地區進行分類。
就產品而言,青黴素的市場佔有率將在2023年至2032年期間以可觀的複合年成長率成長。由於青黴素可有效治療多種細菌感染,其需求量不斷成長。青黴素被認為是一線抗生素,對包括鏈球菌和葡萄球菌在內的各種細菌非常有效。此外,抗生素耐藥菌的增加也產生了對青黴素等強效抗生素的需求,進一步推動了其在醫療領域的需求。
根據給藥方式,2023-2032年口服溶液領域的動物抗生素和抗菌劑市場規模將實現可觀成長。口服溶液給藥方便,可有效治療和預防家畜感染。此外,口服溶液能夠實現精確的劑量控制,便於治療大群動物,因此成為獸醫專業人員和畜牧業者的首選。口服給藥的簡便性和改善動物健康狀況的潛力促使畜牧業對這些產品的需求不斷增加。
就動物而言,由於全球對動物蛋白產品的需求不斷成長,到2032年,畜牧動物細分市場將在動物抗生素和抗菌劑行業中佔據顯著佔有率。隨著集約化養殖越來越普遍,疾病爆發的風險也隨之增加,因此有必要使用抗生素和抗菌藥來預防和治療感染。有效的疾病控制措施和動物健康狀況的改善推動了畜牧業對這些產品的需求。
從區域來看,亞太地區動物抗生素和抗菌劑市場將在2032年實現可觀的成長。快速的城市化和不斷擴大的中產階級導致了動物蛋白消費量的增加,推動了對有效預防和治療家畜疾病的需求。此外,集約化養殖方式的興起以及人們對動物健康和福利意識的提高也促進了該地區對這些產品需求的成長。
.8.3.1.德國
.8.4.1.日本
.8.5.1.巴西
.8.6.1.南非
Global Animal Antibiotics and Antimicrobials Market could grow significantly over 2023-2032, driven by the rising consumption and uptake of animal-based proteins.
The increasing global demand for animal-derived protein products, coupled with the growing population, has led to a rise in intensive animal farming practices, thereby increasing the risk of disease outbreaks. This necessitates using antibiotics and antimicrobials to prevent and treat infections in livestock, which will propel market revenue in the long run. The rising prevalence of zoonotic diseases and the need for disease control measures further contribute to market growth.
According to CDC, scientists estimate that over 6 out of every 10 known infectious illnesses in humans can be transmitted from animals, and 3 out of every 4 new or emerging infectious diseases in people spread from animals. Additionally, favorable government regulations promoting the judicious use of antibiotics and the implementation of strict guidelines for animal health management play a crucial role in shaping the market.
The overall animal antibiotics and antimicrobials market is segregated based on product, mode of delivery, animal, and region.
In terms of product, the market share from the penicillin segment will expand at a decent CAGR from 2023 to 2032. The demand for penicillin is growing due to its effectiveness in treating a wide range of bacterial infections. Penicillin is considered a first-line antibiotic and is highly effective against various bacteria, including streptococci and staphylococci. Besides, the rise of antibiotic-resistant bacteria has created a need for potent antibiotics like penicillin, further driving its demand in the medical field.
Based on the mode of delivery, the animal antibiotics and antimicrobials market size from the oral solutions segment will register appreciable growth over 2023-2032. Oral solutions offer convenient administration and are effective in treating and preventing infections in livestock. Moreover, they enable precise dosage control and facilitate the treatment of large groups of animals, making them a preferred choice for veterinary professionals and livestock farmers. The ease of oral administration and the potential for improved animal health outcomes contribute to the increasing demand for these products in the animal agriculture industry.
With respect to animal, the livestock animal segment will amass a notable share of the animal antibiotics and antimicrobials industry by 2032, attributed to the rising global demand for animal protein products. As intensive farming practices become more prevalent, the risk of disease outbreaks increases, necessitating the use of antibiotics and antimicrobials to prevent and treat infections. Effective disease control measures and improved animal health outcomes drive the demand for these products in the livestock industry.
Regionally, the Asia Pacific animal antibiotics and antimicrobials will accumulate appreciable gains through 2032. Rapid urbanization and the expanding middle class are leading to increased consumption of animal protein, driving the need for effective disease prevention and treatment in livestock. Additionally, the rise of intensive farming practices and the growing awareness of animal health and welfare contribute to the rising demand for these products in the region.
.8.3.1. Germany
.8.4.1. Japan
.8.5.1. Brazil
.8.6.1. South Africa